Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 625.00 | 384.25 | 912.00 | 773.00 | 1.1798 | 1.3564 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 529.00 | 773.00 | 0.6844 | 0.3730 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 625.00 | 384.25 | 349.00 | 773.00 | 0.4515 | -0.0910 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 787.00 | 773.00 | 1.0181 | 1.0359 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 614.00 | 773.00 | 0.7943 | 0.5917 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1493.00 | 1926.00 | 0.7752 | 0.5889 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1835.00 | 1926.00 | 0.9528 | 0.9144 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1790.00 | 1926.00 | 0.9294 | 0.8719 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2031.00 | 1926.00 | 1.0545 | 1.0983 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 894.42 | 1854.00 | 1926.00 | 0.9626 | 0.9323 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 894.42 | 1823.00 | 1926.00 | 0.9465 | 0.9031 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1640.00 | 1926.00 | 0.8515 | 0.7296 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 968.00 | 1926.00 | 0.5026 | 0.0741 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 1296.00 | 1926.00 | 0.6729 | 0.3981 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 894.42 | 2080.00 | 1926.00 | 1.0800 | 1.1440 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2032.00 | 1926.00 | 1.0550 | 1.0992 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 894.42 | 824.00 | 1926.00 | 0.4278 | -0.0714 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 1871.00 | 1926.00 | 0.9714 | 0.9483 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 960.00 | 1926.00 | 0.4984 | 0.0660 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2039.00 | 1926.00 | 1.0587 | 1.1057 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1578.00 | 1926.00 | 0.8193 | 0.6704 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1835.00 | 1926.00 | 0.9528 | 0.9144 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2310.00 | 1926.00 | 1.1994 | 1.3571 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 1250.00 | 894.42 | 1837.00 | 1926.00 | 0.9538 | 0.9163 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 894.42 | 1902.00 | 1926.00 | 0.9875 | 0.9775 |